| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c0953666bc0bcb9edb5da6e5d797fc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8544692b64fac1d68d65786168e0eec3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-902 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 |
| filingDate |
2004-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e25f6a39529f9c8bc16d5bddcf49d01d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8e5c1880ea49101bff0d8d448e8b9c9 |
| publicationDate |
2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004080271-A2 |
| titleOfInvention |
Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| abstract |
This invention concerns in vitro method for prognosticating the progress of breast cancer, comprising detecting or quantifying the level of 17β-hydroxysteroid dehydrogenase (17HSD) type 1 enzyme in breast tumor tissue sample, wherein the presence of said 17HSD type 1 enzyme is indicative of severe progress of breast cancer. Furthermore, the invention also concerns the use of a 17HSD type 1 enzyme inhibitor for prevention or treatment of breast cancer. This invention concerns also the use of compound A in the manufacture of a pharmaceutically acceptable preparation useful as 17HSD inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101087793-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8435973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006063615-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004325692-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7754709-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8080540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8088758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101884706-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8030298-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8288367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008523117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7524853-B2 |
| priorityDate |
2003-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |